JPRN-UMIN000019999已完成1 期
Safety and efficay assessment of adenosine A2A receptor ligand [C-11]Preladenant in healthy volunteers. - First-in-human study of [C-11] Preladenant.
Tokoyo Metropolitan Institute of Gerontology0 个研究点目标入组 15 人开始时间: 2015年12月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1.The subject who has dysfunction in the liver / kidney. 2.The subject who has abnormal findings in the central nervous system. 3.The subject having cardiac failure. 4.The subject with a history of a drug or food allergy. 5.The subject who juddged by the clinical investigator to be inappropriate as a participant in this study.
研究者
相似试验
已完成
1 期
Adenosine, lidocaone, and magnasium cocktail in massive transfusion patientsrepairfusion injury.IRCT20230707058707N1Shiraz University of Medical Sciences17
已完成
3 期
A study on the role of traditional drug based dressings in the treatment of skin wounds produced in breast cancer patients undergoing radiotherapyCTRI/2020/11/029311I110
已完成
1 期
Adenosine versus Verapamil in Paroxysmal Supraventricular Tachycardia (PSVT)Paroxysmal supraventricular tachycardia (psvt).Abnormally rapid heartbeats with sudden onset and cessationIRCT20200202046343N1Mashhad University of Medical Sciences90
终止
3 期
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPICoronary Artery DiseaseNCT01313572Forest Laboratories197
已完成
不适用
Adenosine Administration during and after Primary percutaneous coronary intervention in acute myocardial infarction – a Randomized Controlled Trial (ADAPT).1. Percutaneous coronary intervention<br />2. Myocardial infarction<br /> 3. Reperfusion therapy.NL-OMON22898niversity Medical Center Groningen, <br>Thoraxcenter, Dept Cardiology.450